A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with pik3ca-related overgrowth spectrum

HIGHLIGHTS

  • who: Sarah M. Bernhard MD from the Munich, Germany have published the research work: A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum, in the Journal: (JOURNAL) of February/13,/2021
  • what: The authors evaluated the efficacy and safety of current overgrowth treatment modalities for patients with PROS by performing a systematic review of the current literature.
  • how: The characteristics of the included studies are presented in Table II. In the present systematic review the authors identified 16 studies . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?